Aerie Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AERI Nasdaq 2834 http://www.aeriepharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aerie Pharmaceuticals Inc

Are Aerie Pharmaceuticals Inc’s (NASDAQ:AERI) Interest Costs Too High? - May 17th, 2018 6:11 pm
Wired News – Eli Lilly’s Galcanezumab Met Primary Endpoint in Phase-3 Study for Prevention of Episodic Cluster Headache - May 17th, 2018 5:30 am
Aerie submits second drug for FDA approval - May 15th, 2018 12:43 pm
Benzinga Pro's 5 Stocks To Watch Today - May 15th, 2018 7:04 am
Aerie Pharmaceuticals Submits New Drug Application to U.S. Food and Drug Administration for RoclatanTM (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005% - May 15th, 2018 4:30 am
Aerie (AERI) Incurs Lower Loss in Q1, Launches Rhopressa - May 9th, 2018 6:57 am
With $334M in cash, Aerie preps to break even - May 9th, 2018 6:23 am
Edited Transcript of AERI earnings conference call or presentation 8-May-18 9:00pm GMT - May 8th, 2018 11:45 pm
Aerie: 1Q Earnings Snapshot - May 8th, 2018 2:09 pm
Aerie Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update - May 8th, 2018 2:01 pm
Investor Expectations to Drive Momentum within Roper Technologies, Inter Parfums, SunCoke Energy Partners, Aerie Pharmaceuticals, Forrester Research, and Diamond Hill Investment Group — Discovering Underlying Factors of Influence - May 3rd, 2018 6:10 am
What's in the Cards for Aerie (AERI) This Earnings Season? - May 2nd, 2018 1:39 pm
Durham pharma launches first drug with another on horizon - May 1st, 2018 12:09 pm
Five Stocks To Buy According To Top Biotech-Focused Funds - May 1st, 2018 8:27 am
Aerie Pharmaceuticals Announces Appointment of Concetta Perro as Commercial Counsel - May 1st, 2018 4:30 am
Aerie Pharmaceuticals Announces U.S. Launch of Rhopressa® (netarsudil ophthalmic solution) 0.02% - Apr 30th, 2018 4:30 am
Aerie Pharmaceuticals to Announce First Quarter 2018 Financial Results and Host Conference Call on Tuesday, May 8, 2018 - Apr 26th, 2018 5:30 am
See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. - Apr 16th, 2018 6:04 am
Aerie Pharmaceuticals Announces Appointment of Scott Laranjo as Director, Marketing, Roclatan™ - Apr 12th, 2018 4:30 am
Aerie Pharmaceuticals (AERI) Up 4.6% Since Earnings Report: Can It Continue? - Apr 2nd, 2018 2:55 am